Health Care [ 10/12 ] | Biotechnology [ 46/75 ]
NASDAQ | Common Stock
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.
Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library.
Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 27, 26 | -3.81 Decreased by -2.14 K% | - |
| Nov 14, 25 | -10.81 Decreased by -200.28% | -0.35 Decreased by -2.99 K% |
| Aug 14, 25 | -11.65 Decreased by -4.56 K% | -0.35 Decreased by -3.23 K% |
| May 13, 25 | -4.82 Decreased by -1.05 K% | -0.40 Decreased by -1.10 K% |
| Mar 28, 25 | -0.17 Increased by +88.44% | -0.23 Increased by +26.09% |
| Nov 14, 24 | -3.60 Decreased by -176.92% | -7.80 Increased by +53.85% |
| Aug 12, 24 | -0.25 Increased by +91.78% | -0.55 Increased by +54.55% |
| May 15, 24 | -0.42 Increased by +90.08% | -0.77 Increased by +45.45% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by -100.00% | -2.19 M Increased by +30.45% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -1.87 M Increased by +10.09% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -2.52 M Decreased by -34.04% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -2.18 M Increased by +11.07% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 340.38 K Decreased by -47.40% | -3.15 M Increased by +8.19% | Decreased by -926.81% Decreased by -74.55% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.08 M Increased by +26.16% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.88 M Increased by +70.46% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.46 M Increased by +47.61% | Decreased by N/A% Decreased by N/A% |